How does oral nicotine use affect postoperative recovery?

Oral Nicotine and Postoperative Recovery

Oral nicotine products should not be used perioperatively, as they are associated with increased postoperative complications including elevated pain scores, wound healing problems, and infections—though the risk profile appears less severe than combustible tobacco smoking.

Key Distinction: Nicotine Replacement Therapy vs. Recreational Oral Nicotine

The evidence reveals a critical nuance that must be understood:

Nicotine Replacement Therapy (NRT) for Smoking Cessation

NRT combined with intensive counseling is recommended as part of preoperative smoking cessation programs 1. The ERAS Society guidelines strongly recommend that smoking should cease preoperatively for at least 4 weeks to reduce respiratory and wound-healing complications, with intense counseling and nicotine replacement therapy being most effective 1. This represents therapeutic use to eliminate the far greater harms of continued smoking.

Recreational Oral Nicotine Products (ONPs)

However, recreational oral nicotine product consumption is associated with worse postoperative outcomes and should be discontinued:

• Pain: ONP users had 2.3 times higher odds of elevated pain scores (NRS >3) in the post-anesthesia care unit 2
• Wound complications: Significantly increased rates of wound disruption, infections requiring operative intervention, and seroma formation 3, 4
• Systemic complications: Higher rates of postoperative infections, emergency department visits, and readmissions 5, 3
• Orthopedic healing: 1.9 times higher risk of nonunion and 1.8 times higher risk of reoperation in fracture surgery 6

Evidence Hierarchy and Contradictions

The Cardiac Surgery Caveat

The 2011 ACCF/AHA CABG guidelines present concerning data about NRT safety in the immediate postoperative period 7. Studies showed nicotine replacement therapy was an independent predictor of in-hospital mortality after CABG (OR: 6.06), particularly in critically ill patients. This suggests NRT timing matters—it should not be initiated in the immediate postoperative period for high-risk cardiac patients 7.

Recent Research on Oral Nicotine Products

The most recent studies (2025-2026) specifically examining recreational oral nicotine products consistently demonstrate harm 2, 5, 3, 4, 6. These are distinct from therapeutic NRT patches or gum used for smoking cessation under medical supervision.

Clinical Algorithm

Preoperative Assessment (4-8 weeks before surgery):

1. Active smokers: Initiate intensive smoking cessation with counseling + NRT 1, 8
2. Oral nicotine product users: Counsel for complete cessation; these products increase complications 2, 5, 3
3. Former smokers on NRT: Continue NRT through surgery for smoking cessation maintenance, but discuss timing with anesthesia team for high-risk cardiac cases 7

Perioperative Period:

• Continue NRT for smoking cessation patients (except immediate post-cardiac surgery) 8
• Avoid initiating NRT in the immediate postoperative period for cardiac surgery patients 7
• Recreational oral nicotine products should remain discontinued 2, 5, 3

Post-discharge:

• Maintain smoking cessation support with continued NRT and follow-up for at least 1 month 8
• Counsel against resumption of any nicotine products 8

Critical Pitfalls to Avoid

1. Conflating therapeutic NRT with recreational nicotine use: The former is part of evidence-based smoking cessation; the latter increases complications
2. Delaying necessary surgery for smoking cessation: While 4-8 weeks of preoperative cessation is ideal, surgery should not be delayed for this purpose, particularly for cancer 9
3. Assuming "nicotine-free" means risk-free: Even 2-4 weeks of cessation may not reduce respiratory complications; benefits accrue after 4+ weeks 1, 8
4. Ignoring the cardiac surgery exception: NRT may increase mortality risk in immediate post-CABG period 7

Quality of Life and Morbidity Impact

The evidence prioritizes morbidity reduction through:

• Wound healing: 4-8 weeks nicotine-free reduces wound complications 1, 8
• Respiratory complications: Significant reduction only after 4+ weeks cessation 1, 8
• Pain management: Oral nicotine users experience higher pain scores 2, though some studies suggest low-dose therapeutic nicotine may have analgesic effects in non-smokers 10, 11—this remains investigational and cannot be recommended clinically

The strongest evidence supports complete nicotine cessation from all sources (smoking and oral products) for at least 4 weeks preoperatively, with the exception of therapeutic NRT as part of supervised smoking cessation programs 1, 12, 8.